Target intelligence / Profile preview

Ras-related protein Rab-39B (RAB39B)

Target
RAB39B
Molecular classification
Small GTPase, Vesicle trafficking protein, Enzyme (GTPase activity), RAB GTPase family member, RAS superfamily protein
01

Overview

Ras-related protein Rab-39B is a member of the RAB family of small GTPases involved in intracellular vesicular trafficking. RAB39B is primarily expressed in the brain and regulates the trafficking of proteins such as glutamate receptor subunits (especially GluA2) and synaptic structure maintenance. Loss-of-function mutations in RAB39B are causally linked to X-linked intellectual disability, Parkinson’s disease, and autism spectrum disorder. RAB39B acts by interacting with effector proteins including PICK1 and modulating both AMPA and NMDA receptor localization, as well as regulating basal autophagy via the PI3K-AKT-mTOR signaling pathway. Research models indicate that targeting RAB39B pathways (e.g., with rapamycin for autophagy) can partially rescue cognitive and synaptic deficits associated with RAB39B deficiency, but direct targeting in humans for therapy remains experimental and is associated with notable neurodevelopmental risks.

Other names
RAB39BBGMRMRX72WSMNWSNXLID72Waisman syndromeras-related protein Rab-39B
02

Mechanism of action

Modulation of autophagy via mTOR inhibition

03

Biological functions

Regulation of vesicular traffickingAutophagy modulationSynapse formation and maintenanceAMPA receptor traffickingPI3K-AKT-mTOR pathway regulation
04

Disease associations

Neurodevelopmental disorder (e.g., X-linked intellectual disability)Parkinson’s diseaseAutism spectrum disorderNeurodegenerative disease
05

Safety considerations

Potential for altered synaptic function and cognitive impairment if modulatedOff-target effects or downstream neurodevelopmental impact due to autophagy modulation
06

Interacting drugs

Rapamycin (as an indirect pharmacological tool in research)
07

Biomarkers

Mutations in RAB39B (for X-linked intellectual disability, Parkinson's, autism)

Beyond the preview

Go deeper on Ras-related protein Rab-39B (RAB39B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ras-related protein Rab-39B (RAB39B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call